Literature DB >> 20681317

Biology and applications of mesenchymal stem cells.

Pedro Cesar Chagastelles1, Nance Beyer Nardi, Melissa Camassola.   

Abstract

Undifferentiated adult stem cells are responsible for cell replacement in adult organisms. Initially isolated from the bone marrow, they are now known to be distributed throughout the organism as a whole, with a perivascular location. They are defined by properties which include proliferation as adherent cells, a defined immunophenotype, and the capacity to differentiate in vitro into osteoblasts, adipocytes and chondroblasts. Mesenchymal stem cells (MSCs) are considered as one of the most promising cell types for therapeutic applications. Mechanisms responsible for this therapeutic role are not well understood, and may involve diferentiation or, as most evidences point out, paracrine activity. The ability to modulate the immune system opens a wide range of applications, mainly for autoimmune diseases and graft-versus-host disease. Preclinical and clinical studies show promising results, but controversial results are still reported, indicating the need for further basic and preclinical investigation on their therapeutic potential. This review will focus on recent advances in understanding MSC biology and applications in cell therapy.

Entities:  

Mesh:

Year:  2010        PMID: 20681317     DOI: 10.3184/003685010x12708175591515

Source DB:  PubMed          Journal:  Sci Prog        ISSN: 0036-8504            Impact factor:   2.774


  14 in total

1.  Conditioned Medium from Adipose-Derived Stem Cells (ADSCs) Promotes Epithelial-to-Mesenchymal-Like Transition (EMT-Like) in Glioma Cells In vitro.

Authors:  Isabele C Iser; Stefanie M Ceschini; Giovana R Onzi; Ana Paula S Bertoni; Guido Lenz; Márcia R Wink
Journal:  Mol Neurobiol       Date:  2015-12-19       Impact factor: 5.590

2.  Stem Leydig cell differentiation: gene expression during development of the adult rat population of Leydig cells.

Authors:  Erin L Stanley; Daniel S Johnston; Jinjiang Fan; Vassilios Papadopoulos; Haolin Chen; Ren-Shan Ge; Barry R Zirkin; Scott A Jelinsky
Journal:  Biol Reprod       Date:  2011-08-10       Impact factor: 4.285

3.  Meta-analysis of preclinical studies of mesenchymal stromal cells for ischemic stroke.

Authors:  Quynh Vu; Kate Xie; Mark Eckert; Weian Zhao; Steven C Cramer
Journal:  Neurology       Date:  2014-03-07       Impact factor: 9.910

4.  Improved Post-Thaw Function and Epigenetic Changes in Mesenchymal Stromal Cells Cryopreserved Using Multicomponent Osmolyte Solutions.

Authors:  Kathryn Pollock; Rebekah M Samsonraj; Amel Dudakovic; Roman Thaler; Aron Stumbras; David H McKenna; Peter I Dosa; Andre J van Wijnen; Allison Hubel
Journal:  Stem Cells Dev       Date:  2017-03-15       Impact factor: 3.272

5.  Comparison of phenotypic markers and neural differentiation potential of multipotent adult progenitor cells and mesenchymal stem cells.

Authors:  Saurabh Pratap Singh; Naresh Kumar Tripathy; Soniya Nityanand
Journal:  World J Stem Cells       Date:  2013-04-26       Impact factor: 5.326

6.  Future research and therapeutic applications of human stem cells: general, regulatory, and bioethical aspects.

Authors:  Antonio Liras
Journal:  J Transl Med       Date:  2010-12-10       Impact factor: 5.531

Review 7.  Autism spectrum disorders: is mesenchymal stem cell personalized therapy the future?

Authors:  Dario Siniscalco; Anna Sapone; Alessandra Cirillo; Catia Giordano; Sabatino Maione; Nicola Antonucci
Journal:  J Biomed Biotechnol       Date:  2012-02-13

8.  Different tenogenic differentiation capacities of different mesenchymal stem cells in the presence of BMP-12.

Authors:  Linghui Dai; Xiaoqing Hu; Xin Zhang; Jingxian Zhu; Jiying Zhang; Xin Fu; Xiaoning Duan; Yingfang Ao; Chunyan Zhou
Journal:  J Transl Med       Date:  2015-06-24       Impact factor: 5.531

9.  In vivo MR detection of fluorine-labeled human MSC using the bSSFP sequence.

Authors:  Emeline J Ribot; Jeffrey M Gaudet; Yuhua Chen; Kyle M Gilbert; Paula J Foster
Journal:  Int J Nanomedicine       Date:  2014-04-08

10.  Delivery of Functional Anti-miR-9 by Mesenchymal Stem Cell-derived Exosomes to Glioblastoma Multiforme Cells Conferred Chemosensitivity.

Authors:  Jessian L Munoz; Sarah A Bliss; Steven J Greco; Shakti H Ramkissoon; Keith L Ligon; Pranela Rameshwar
Journal:  Mol Ther Nucleic Acids       Date:  2013-10-01       Impact factor: 10.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.